We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we'll assume that you are happy to receive all cookies on the medicines.ie website. Find out more

Janssen-Cilag Ltd

50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG, UK
Telephone: +44 1494 567 567
Fax: +44 1494 567 568
Medical Information Direct Line: +353 1 800 709 122
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +353 1 620 2300
Medical Information Facsimile: +44 (0) 1494 567 445
Patient Information Leaflet last updated on medicines.ie: 15/06/2017
PIL Sublimaze 50 micrograms/ml, Solution for Injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 15/06/2017 and displayed until Current
Reasons for adding or updating:
  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision
Updated on 13/06/2017 and displayed until 15/06/2017
Reasons for adding or updating:
  • Change to section 3 - dose and frequency
  • Change to section 3 - use in children/adolescents
  • Change to section 3 - how to take/use
  • Change to section 6 - date of revision
Updated on 13/04/2015 and displayed until 13/06/2017
Reasons for adding or updating:
  • Change to information about pregnancy or lactation
  • Change to information about driving or using machinery
  • Change to date of revision
Updated on 16/09/2014 and displayed until 13/04/2015
Reasons for adding or updating:
  • Change to date of revision
  • Change to improve clarity and readability
  • Addition of information on reporting a side effect.
Updated on 26/06/2013 and displayed until 16/09/2014
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
  • Change to date of revision
Updated on 01/06/2012 and displayed until 26/06/2013
Reasons for adding or updating:
  • Change to date of revision
  • Change to name of manufacturer
Updated on 22/03/2011 and displayed until 01/06/2012
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 25/05/2010 and displayed until 22/03/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change due to user-testing of patient information
Updated on 28/07/2009 and displayed until 25/05/2010
Reasons for adding or updating:
  • Change to drug interactions
  • Change to date of revision
  • Change to side-effects
Updated on 13/11/2008 and displayed until 28/07/2009
Reasons for adding or updating:
  • Change to marketing authorisation holder address
Updated on 14/07/2008 and displayed until 13/11/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to marketing authorisation holder address
Updated on 24/06/2008 and displayed until 14/07/2008
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 24/01/2007 and displayed until 24/06/2008
Reasons for adding or updating:
  • Change to storage instructions
  • Change to date of revision
Updated on 15/09/2004 and displayed until 24/01/2007
Reasons for adding or updating:
  • New PIL for medicines.ie

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
   fentanyl citrate